#alzheimer's prevention

Discover 2 curated intelligence briefings related to this specific topic.

Repurposing Existing Molecules Slashes Clinical Risk
Technology & Innovation

Repurposing Existing Molecules Slashes Clinical Risk

A master practitioner's approach to constructing a drug repurposing pipeline, leveraging public bio-databases to bypass the multi-billion dollar gamble of de novo drug discovery.

Read Analysis
The Neural Pivot: Why GLP-1s are Redefining the Frontier of Brain Health
Health & Medicine

The Neural Pivot: Why GLP-1s are Redefining the Frontier of Brain Health

New data reveals that GLP-1 receptor agonists are moving beyond the scale. With millions of prescriptions flooding the UK market and emerging evidence linking these drugs to reduced Alzheimer's risk, the pharmaceutical industry is pivoting toward the brain.

Read Analysis